Related references
Note: Only part of the references are listed.Analysis of Human APOBEC3H Haplotypes and Anti-Human Immunodeficiency Virus Type 1 Activity
Xiaojun Wang et al.
JOURNAL OF VIROLOGY (2011)
Two-stepping through time: mammals and viruses
Nicholas R. Meyerson et al.
TRENDS IN MICROBIOLOGY (2011)
Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
John S. Albin et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2010)
A Single Amino Acid in Human APOBEC3F Alters Susceptibility to HIV-1 Vif
John S. Albin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Single Amino Acid Difference in Human APOBEC3H Variants Determines HIV-1 Vif Sensitivity
Anjie Zhen et al.
JOURNAL OF VIROLOGY (2010)
The Range of Human APOBEC3H Sensitivity to Lentiviral Vif Proteins
Melody M. H. Li et al.
JOURNAL OF VIROLOGY (2010)
Lentiviral Vif Degrades the APOBEC3Z3/APOBEC3H Protein of Its Mammalian Host and Is Capable of Cross-Species Activity
Rebecca S. LaRue et al.
JOURNAL OF VIROLOGY (2010)
Stably Expressed APOBEC3F Has Negligible Antiviral Activity
Eri Miyagi et al.
JOURNAL OF VIROLOGY (2010)
Moderate Influence of Human APOBEC3F on HIV-1 Replication in Primary Lymphocytes
Lubbertus C. F. Mulder et al.
JOURNAL OF VIROLOGY (2010)
Identification of Specific Determinants of Human APOBEC3F, APOBEC3C, and APOBEC3DE and African Green Monkey APOBEC3F That Interact with HIV-1 Vif
Jessica L. Smith et al.
JOURNAL OF VIROLOGY (2010)
The Localization of APOBEC3H Variants in HIV-1 Virions Determines Their Antiviral Activity
Marcel Ooms et al.
JOURNAL OF VIROLOGY (2010)
Long-Term Restriction by APOBEC3F Selects Human Immunodeficiency Virus Type 1 Variants with Restored Vif Function
John S. Albin et al.
JOURNAL OF VIROLOGY (2010)
APOBEC3 proteins mediate the clearance of foreign DNA from human cells
Mark D. Stenglein et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction
Eric W. Refsland et al.
NUCLEIC ACIDS RESEARCH (2010)
Human cellular restriction factors that target HIV-1 replication
Klaus Strebel et al.
BMC MEDICINE (2009)
Inhibition of HIV-1 Infection and Replication by Enhancing Viral Incorporation of Innate Anti-HIV-1 Protein A3G A NON-PATHOGENIC Nef MUTANT-BASED ANTI-HIV STRATEGY
Linden A. Green et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Polymorphisms and Splice Variants Influence the Antiretroviral Activity of Human APOBEC3H
Ariana Harari et al.
JOURNAL OF VIROLOGY (2009)
Analysis of the Percentage of Human Immunodeficiency Virus Type 1 Sequences That Are Hypermutated and Markers of Disease Progression in a Longitudinal Cohort, Including One Individual with a Partially Defective Vif
Anne Piantadosi et al.
JOURNAL OF VIROLOGY (2009)
Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent
Edward P. Browne et al.
VIROLOGY (2009)
Host Restriction Factors Blocking Retroviral Replication
Daniel Wolf et al.
ANNUAL REVIEW OF GENETICS (2008)
The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals
Rebecca S. Larue et al.
BMC MOLECULAR BIOLOGY (2008)
HIV-1 accessory proteins - Ensuring viral survival in a hostile environment
Michael H. Malim et al.
CELL HOST & MICROBE (2008)
Antiretroelement activity of APOBEC3H was lost twice in recent human evolution
Molly OhAinle et al.
CELL HOST & MICROBE (2008)
Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G
Guylaine Hache et al.
CURRENT BIOLOGY (2008)
Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization
Mark D. Stenglein et al.
JOURNAL OF VIROLOGY (2008)
Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya
Allison M. Land et al.
JOURNAL OF VIROLOGY (2008)
The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction
April J. Schumacher et al.
JOURNAL OF VIROLOGY (2008)
Small-molecule inhibition of HIV-1 Vif
Robin Nathans et al.
NATURE BIOTECHNOLOGY (2008)
Vpr.A3A chimera inhibits HIV replication
Renato S. Aguiar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins
Cesar A. Virgen et al.
JOURNAL OF VIROLOGY (2007)
Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1
Eri Miyagij et al.
JOURNAL OF VIROLOGY (2007)
Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription
S. Henriet et al.
NUCLEIC ACIDS RESEARCH (2007)
Evolutionary and biomedical insights from the rhesus macaque genome
Richard A. Gibbs et al.
SCIENCE (2007)
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation - Comparisons with APOBEC3G
Rebecca K. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family
Ying Dang et al.
JOURNAL OF VIROLOGY (2006)
APOBEC3 proteins inhibit human LINE-1 retrotransposition
Heide Muckenfuss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism
Mark D. Stenglein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates
Veronique Zennou et al.
VIROLOGY (2006)
Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H
M OhAinle et al.
JOURNAL OF VIROLOGY (2006)
The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest
K Sakai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
HIV vaccine design: insights from live attenuated SIV vaccines
WC Koff et al.
NATURE IMMUNOLOGY (2006)
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
BP Doehle et al.
VIROLOGY (2005)
G→A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo
TL Kieffer et al.
JOURNAL OF VIROLOGY (2005)
Recovery of APOBEC3-edited human immunodeficiency virus G -> A hypermutants by differential DNA denaturation PCR
R Suspene et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities
MA Langlois et al.
NUCLEIC ACIDS RESEARCH (2005)
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
SL Sawyer et al.
PLOS BIOLOGY (2004)
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
KN Bishop et al.
CURRENT BIOLOGY (2004)
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo
MT Liddament et al.
CURRENT BIOLOGY (2004)
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
Q Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
HL Wiegand et al.
EMBO JOURNAL (2004)
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
R Mariani et al.
CELL (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4+ T cells
M Janini et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
